UnitedHealth Group Incorporated Common Stock (DE)
UNH evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for UNH—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$364.13B
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Mar 31, 2026.
Run UnitedHealth Group Incorporated Common Stock (DE) through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available UnitedHealth Group Incorporated Common Stock (DE) facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
OCF $8.9B · Net income $6.3B · Debt/OCF 1.4×
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 1 sell (180d)
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
3,020
Total value held
$216.84B
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 117,741,554 | $31.86B |
| blackrock, inc. | 73,467,531 | $19.88B |
| state street corp | 45,332,186 | $12.27B |
| susquehanna international group, llp | 29,689,281 | $8.03B |
| vanguard portfolio management llc | 24,036,504 | $6.50B |
| geode capital management, llc | 22,768,695 | $6.14B |
| charles schwab investment management inc | 20,817,755 | $5.63B |
| citadel advisors llc | 17,764,330 | $4.81B |
| morgan stanley | 14,963,569 | $4.05B |
| jane street group, llc | 13,084,480 | $3.54B |
Showing top 10 of 3,020 institutional holders of UnitedHealth Group Incorporated Common Stock (DE). Open the full 13F history after sign-in.
Short Interest
as of May 10, 2026- % of float
- 1.9%
- Days to cover
- 1.7
- Shares short
- 15,177,651
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
UNH short interestGovernance
Frequently asked questions
Who is the CEO of UnitedHealth Group Incorporated Common Stock (DE)?
Mr. Stephen J. Hemsley is the chief executive officer of UnitedHealth Group Incorporated Common Stock (DE) (UNH).
Where is UnitedHealth Group Incorporated Common Stock (DE) headquartered?
UnitedHealth Group Incorporated Common Stock (DE) (UNH) is headquartered in Eden Prairie, MN, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.